Efficacy of subcutaneous <i>vs</i> intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trialArnaud Constantin, Dae‐Hyun Yoo, Christopher J Edwards et al.|Lara D. Veeken|2022Cited by 6